CC-4047

· Celgene Corporation

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for CC-4047, covering 2006-12-19 to 2014-05-09. Get the full timeline:

Most recent: Clinical Trial Update: CC-4047 in Treating Patients With Myelofibrosis [Phase 1, Phase 2]